The highest FGF-23 levels (4th quartile, >93.53 RU/mL) were associated with CV outcomes: combined CV death or HF hospitalization, CV death, HF hospitalization, all-cause mortality, combined CV death/MI/stroke, stroke, and atrial fibrillation but not MI. This evidence concerns the gene FGF23 and hydrops fetalis.